Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America RNA Analysis Market, by Product
1.4.2 North America RNA Analysis Market, by Technology
1.4.3 North America RNA Analysis Market, by End-use
1.4.4 North America RNA Analysis Market, by Application
1.4.5 North America RNA Analysis Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2022, Jun) Leading Players
Chapter 4. North America RNA Analysis Market by Product
4.1 North America Kits & Reagents Market by Country
4.2 North America Instruments Market by Country
4.3 North America Services Market by Country
Chapter 5. North America RNA Analysis Market by Technology
5.1 North America Real Time-PCR (qPCR) Technology Market by Country
5.2 North America Sequencing Technology Market by Country
5.3 North America Microarray Technology Market by Country
5.4 North America Others Market by Country
Chapter 6. North America RNA Analysis Market by End-use
6.1 North America Government Institutes & Academic Centers Market by Country
6.2 North America Hospitals & Clinics Market by Country
6.3 North America Pharmaceutical & Biotechnology Companies Market by Country
6.4 North America Contract Research Organizations (CROs) Market by Country
Chapter 7. North America RNA Analysis Market by Application
7.1 North America Infectious Diseases & Pathogenesis Market by Country
7.2 North America Epigenetics Market by Country
7.3 North America RNA Structure & Molecular Dynamics Market by Country
7.4 North America Development & Delivery of RNA Therapeutics Market by Country
7.5 North America Construction of RNA Expression Atlas Market by Country
7.6 North America Alternative RNA Splicing Market by Country
7.7 North America Others Market by Country
Chapter 8. North America RNA Analysis Market by Country
8.1 US RNA Analysis Market
8.1.1 US RNA Analysis Market by Product
8.1.2 US RNA Analysis Market by Technology
8.1.3 US RNA Analysis Market by End-use
8.1.4 US RNA Analysis Market by Application
8.2 Canada RNA Analysis Market
8.2.1 Canada RNA Analysis Market by Product
8.2.2 Canada RNA Analysis Market by Technology
8.2.3 Canada RNA Analysis Market by End-use
8.2.4 Canada RNA Analysis Market by Application
8.3 Mexico RNA Analysis Market
8.3.1 Mexico RNA Analysis Market by Product
8.3.2 Mexico RNA Analysis Market by Technology
8.3.3 Mexico RNA Analysis Market by End-use
8.3.4 Mexico RNA Analysis Market by Application
8.4 Rest of North America RNA Analysis Market
8.4.1 Rest of North America RNA Analysis Market by Product
8.4.2 Rest of North America RNA Analysis Market by Technology
8.4.3 Rest of North America RNA Analysis Market by End-use
8.4.4 Rest of North America RNA Analysis Market by Application
Chapter 9. Company Profiles
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 Qiagen N.V.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Acquisition and Mergers:
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.9 Merck Group
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Acquisition and Mergers:
9.10. Promega Corporation
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:
9.10.2.2 Geographical Expansions:
Unique Offerings 